Document ID: chunk:federal_register_of_legislation:F2022C00752:reg:7:p2
Version: federal_register_of_legislation:F2022C00752
Segment Type: reg
Provision Reference: reg 7 (pt 2/2)
Character Range: 13347–14988

= Subdivision(s)
effect                                          SLI = Select Legislative Instrument
(md not incorp) = misdescribed amendment        SR = Statutory Rules
cannot be given effect                          Sub‑Ch = Sub‑Chapter(s)
mod = modified/modification                     SubPt = Subpart(s)
No. = Number(s)                                 underlining = whole or part not
                                                commenced or to be commenced

Endnote 3—Legislation history

Name                                                                                                                                                                                                             Registration                  Commencement                 Application, saving and transitional provisions
Industry Research and Development (clinical trials, phase 0, I, II, III, pre-market pilot stage, pre-market pivotal stage, for an unapproved therapeutic good) Determination 2022                                31 March 2022 (F2022N00078)   1 April 2022 (s 2)

Industry Research and Development (clinical trials, phase 0, I, II, III, pre-market pilot stage, pre-market pivotal stage, for an unapproved therapeutic good) Amendment (Minor Corrections) Determination 2022  29 Jun 2022 (F2022N00150)     30 Jun 2022 (s 2(1) item 1)

Endnote 4—Amendment history

Provision affected         How affected
Title....................  am F2022N00150
Part 1
s 1.....................   am F2022N00150
s 2.....................   rep LA, s 48D
s 4.....................   am F2022N00150
Part 2
s 6.....................   am F2022N00150